Industries > Pharma > Medical Device Outsourcing Report 2019-2029

Medical Device Outsourcing Report 2019-2029

Analysis by Product (Finished goods, Electronics, Raw Materials), by Device Type (Class I Devices, Class II Devices, Class III Devices), by Application (Orthopaedics and Spine, Cardiovascular, Radiology, General Medical Devices, Others) and by Region (North America, Europe, Asia Pacific, Latin America, MEA), Company and Country Analysis and Forecasts

PAGES: 185
PRODUCT CODE: PHA0451
SUBMARKET: Digital Healthcare

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE
SKU: PHA0451 Categories: , Tag:

Market Definition:
• A medical device is any instrument, software, implement, machine, appliance, apparatus, reagent for in vitro use, implant, material or other similar or related article, deliberated by the manufacturer to be used, alone or in combination, for human beings, for specific medical purposes.
• These devices benefit patients by providing them health care diagnose and treat and help them to control disease or sickness further improving their quality of life.

Market Overview and Trends
• With the rising demand for advanced products and increase in competition amongst the manufacturers is moving towards the development of products at lower cost.
• It can also be predicted that the growing inclination towards outsourcing services like product implementation, regulatory consulting and quality assurance can enlarge the medical device outsourcing market.
• Decreases in the overall cost, reduction in the time required by the manufacturers to take part in the market are some of the evidences of increase in the medical outsourcing market.
• The outsourcing also permits the companies to centre its interest on their main objectives such as marketing of the medical device.

Market Dynamics:

Factors Influencing the Market Growth:
• The factors driving the Global Medical Device Outsourcing markets are- Introduction of new and innovative products, rising costs for hospital and increasing demand of medical devices, need for cost effective products, and others. Several development programs held by Polymer Science and Engineering Department by the University of Massachusetts for the growth of medical device industry and also help to generate skilled workers.
• The increasing demand for medical devices along with the rising price competition and requirement to reduce cost is projected to drive the growth of the market during the forecast period.
• The changing regulatory landscape and increasing tendency towards outsourcing services for example, quality assurance, regulatory consulting, and product implementation are expected to the growth of market during the forecast period.

Factors Restraining the Market Growth:
• The factors restraining the market growth are the threat of loss of confidential information, constant cost pressures and reimbursement policies could affect the growth rate of the Global Medical Device Outsourcing market.

Market Segmentation 2019-2029:
The Global Medical Device Outsourcing market is segmented on the product, device type, application and region.

1. Global Medical Device Outsourcing, by Product
a) Finished goods
b) Electronics
c) Raw Materials

2. Global Medical Device Outsourcing, by Device Type
a) Class I Devices
b) Class II Devices
c) Class III Devices

3. Global Medical Device Outsourcing, by Application
a) Orthopaedics and Spine
b) Cardiovascular
c) Radiology
d) General Medical Devices
e) Others

4. Global Medical Device Outsourcing, by Region
a) North America
– US
– Canada
b) Europe
– Germany
– UK
– France
– Rest of Europe
c) Asia Pacific
– Japan
– China
– India
– Rest of Asia Pacific
d) Rest of the World (RoW)

Competitive Analysis:
• Research and development is the primary strategy adopted by the key players in the Global Biodefense market.
• These companies have developed various strategies and developments such as product launch, partnerships, mergers & acquisitions, joint venture, and collaborations.

Major Market Players:
Celestica, Inc., Creganna, Flextronics International Ltd., Heraeus Holding, Integer Holdings Corporation, Nortech Systems, Inc., Plexus Corp., Sanmina Corporation, Tecomet, Inc., and West Pharmaceutical Services, Inc.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Medical Device Outsourcing Report 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Medical Device Outsourcing Report 2019-2029


Latest Pharma news

“Biological Drug API Manufacturing market set to grow to $11bn by 2025” says Visiongain report

Strengths in the biotech contract manufacturing market, from the perspective of the CMOs, stem from the demand for lower cost manufacturing from companies of all sizes.

07 November 2019

READ

“global radiation oncology market is anticipated to surpass USD 6.5 billion by 2020”, says Visiongain

Growing aging population, urbanization, and growing wealth in low- and middle-income countries such as China and India are anticipated to boost the APAC radiation oncology market.

07 November 2019

READ

“Global Rabies Diagnostics Market is anticipated to surpass USD 1.8 billion by 2020”, says Visiongain

Several international healthcare organizations are working with healthcare organizations to develop and market new detection assays to drive efforts aimed at fighting the disease.

07 November 2019

READ

“Global spinal muscular atrophy (SMA) market is anticipated is to surpass USD 950 Million by 2020”, says Visiongain

Increasing awareness of SMA and increasing numbers of programs to expand treatment options for rare diseases are key factors that are boosting the market growth.

07 November 2019

READ

Categories

Category